Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT03016572 Completed - Anxiety Disorders Clinical Trials

Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for Suicide

PASS
Start date: May 4, 2017
Phase: N/A
Study type: Interventional

This research study is designed to answer specific questions about new ways to provide services for youth at-risk of suicide.

NCT ID: NCT03016052 Completed - Clinical trials for Generalized Anxiety Disorder

Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Anxiety

Start date: May 2016
Phase: N/A
Study type: Interventional

this study examines the emergence of the visual mismatch negativity (vMMN) ERP component in response to deviations from the embedded contingency in attention bias modification treatment (ABMT) for social and generalized anxiety, and the interaction between vMMN emergence and clinical improvement. ***As of September 2017, recruitment of SAD participants has concluded.

NCT ID: NCT03015285 Not yet recruiting - Major Depression Clinical Trials

CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT

Start date: January 2017
Phase: N/A
Study type: Interventional

Adults with high anxiety sensitivity (AS) and a mental health diagnosis of anxiety, depression, or posttraumatic stress will be recruited and will be randomly assigned to either transdiagnostic cognitive behavioural therapy (CBT) for AS or disorder-specific CBT for their primary mental health problem. The study outcomes - AS, anxiety, mood, and substance use symptoms, and functional impairment - will be assessed at pre-and post-treatment and 6 and 12 months post-treatment via standardized self-report measures completed by participants and a standardized diagnostic interview.

NCT ID: NCT03013777 Completed - Anxiety Disorders Clinical Trials

A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia

Start date: December 6, 2016
Phase: N/A
Study type: Interventional

To determine the effect of cognitive behavioral therapy (CBT) in the severity of anxiety and depression in adult patients with familial dysautonomia. Patients will be enrolled in an 8-week CBT program. All CBT sessions will be done either in person at the NYU Dysautonomia Center or over the phone to help accommodate disability and potential physical limitations of our patient population.

NCT ID: NCT03001154 Completed - Anxiety Clinical Trials

Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software

VRETORIK
Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Virtual Reality Exposure Therapy (VRET) is an efficacious treatment of fear and anxiety, but because of the high financial costs and technical complexity of the past generation of VR hardware, there has been no large-scale implementation of this promising treatment. The present study will investigate whether off-the-shelf, commercial VR hardware and software can be used as stimuli material to conduct in-session exposure therapy for speech anxiety. The study will recruit n=25+25 participants from the general public suffering from substantial speech anxiety, who will be randomized to either a waiting-list, or one-session VRET with a therapist, followed by four weeks of a progressive maintenance program encouraging in-vivo exposure. The waiting-list group will then receive an Internet-delivered VRET treatment program.

NCT ID: NCT02998801 Completed - Anxiety Clinical Trials

Alleviating Pre-operative Anxiety With Innovative 3D Immersive Virtual Reality

VR-Anxiety
Start date: November 2016
Phase: N/A
Study type: Interventional

To construct and evaluate an immersive 3D simulation to familiarize patients with the pre-operative experience, and investigate whether A) immersive 3D virtual reality video can reduce pre-operative anxiety, and B) how this approach compares to current practice of viewing traditional educational videos.

NCT ID: NCT02998502 Completed - Anxiety Clinical Trials

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens

Start date: September 2016
Phase: N/A
Study type: Interventional

This study will test the efficiency of the Freespira Breathing System in youth.

NCT ID: NCT02981238 Completed - Clinical trials for Sleep Disorders Related to Anxiety

Phytotherapy Strategy for Sleep Disorders Related to Anxiety With a Combination of Eschscholtzia and Valerian Extracts

Start date: September 20, 2016
Phase:
Study type: Observational

The aim of the study is to evaluate the effect of a one-month supplementation with Phytostandard® Eschscholtzia and valerian on the Insomnia Severity Index (ISI), in insomniac so-called adjustment subjects (occasional or short-term insomnia)

NCT ID: NCT02977923 Completed - Pain Clinical Trials

Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: a Pilot Study

DREAM-P
Start date: July 10, 2017
Phase: N/A
Study type: Interventional

Children with injuries, including burns, experience severe pain intensity during medical procedures despite the increasing doses of analgesics. Current guidelines on pediatric procedural pain management recommend the combination of non-pharmacological and pharmacological interventions to enhance pain management and decrease the numerous side effects of analgesics. Virtual reality (VR) has gained growing consideration as a non-pharmacological method as it engages multiple senses and allows interactions with a virtual world. Oculus Rift ® (OR) is a new technology in VR that provides more immersiveness, at a relatively low cost, and could probably improve the management of pain and anxiety in wound care. Overall hypothesis: Distraction by VR via the OR, in combination with the standard pharmacological treatment, is a feasible, acceptable and satisfactory method for the management of pain and anxiety during wound-related treatments in children with injuries. Note that this pilot study will precede a larger trial aimed at assessing the effect of virtual reality distraction via the Oculus Rift ® (DREAM-T: NCT02947243)

NCT ID: NCT02964520 Completed - Anxiety Clinical Trials

EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety

Start date: July 2015
Phase: N/A
Study type: Interventional

This study evaluates if individuals with moderate to high trait anxiety can learn how to self-regulate their brain waves and reduce their trait anxiety in ten sessions of EEG alpha-theta neurofeedback training. Half of the randomly assigned participants will receive alpha/theta neurofeedback training while the other half will receive a two-part control protocol where low beta and beta waves will be uptrained in and downtrained in in successive sessions.